Gradientech Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.24M

  • Investors
  • 13

Gradientech General Information

Description

Developer of an antibiotic susceptibility testing system designed to provide live imaging of cell behaviour in response to defined concentration gradients. The company's system combines microfluidics with live imaging to analyze bacterial responses on a linear antibiotic concentration gradient and provides rapid antibiotic susceptibility testing of positive blood culture samples from sepsis patients, enabling healthcare sector clients to analyze live-cell responses with full control of the chemotactic environment.

Contact Information

Website
www.gradientech.se
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Uppsala Science Park
  • 751 83 Uppsala
  • Sweden
+46 018-418
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • Uppsala Science Park
  • 751 83 Uppsala
  • Sweden
+46 018-418

Gradientech Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gradientech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 01-Apr-2024 $6.24M Completed Generating Revenue
12. Secondary Transaction - Private 18-Jan-2023 Completed Generating Revenue
11. Secondary Transaction - Private 01-Aug-2022 Completed Generating Revenue
10. Later Stage VC 01-Sep-2020 Completed Generating Revenue
9. Accelerator/Incubator 27-Mar-2020 Completed Generating Revenue
8. Later Stage VC 03-Apr-2019 Completed Generating Revenue
7. Later Stage VC 30-Aug-2018 Completed Generating Revenue
6. Grant 26-Mar-2018 Completed Generating Revenue
5. Later Stage VC 09-Dec-2016 $1.11M $5.31M Completed Generating Revenue
4. Grant 20-Nov-2014 $679K $4.2M Completed Generating Revenue
To view Gradientech’s complete valuation and funding history, request access »

Gradientech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares 38,029 $25.75 $25.75 1x $25.75 2.14%
Ordinary Shares 12,198 $7.87 $7.87 1x $7.87 0.69%
To view Gradientech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Gradientech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an antibiotic susceptibility testing system designed to provide live imaging of cell behaviour in response
Diagnostic Equipment
Uppsala, Sweden
36 As of 2022

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gradientech Competitors (1)

One of Gradientech’s competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA
You’re viewing 1 of 1 competitors. Get the full list »

Gradientech Patents

  • 31

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Gradientech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4771640-A1 Resistance and/or resistance mechanism prediction Pending 30-Aug-2023
WO-2025048699-A1 Resistance and/or resistance mechanism prediction Inactive 30-Aug-2023
EP-4499762-A1 Adherence enhancing coating for plastic surfaces Pending 28-Mar-2022
EP-4499762-A4 Adherence enhancing coating for plastic surfaces Pending 28-Mar-2022
US-20250197664-A1 Adherence enhancing coating for plastic surfaces Pending 28-Mar-2022 C09D105/00
To view Gradientech’s complete patent history, request access »

Gradientech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gradientech Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hardy Diagnostics Corporation Minority
Polynom Investment Venture Capital Minority
Axilium Holding Venture Capital Minority
Angel (individual) Minority
European Structural And Investment Funds Government Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Gradientech FAQs

  • When was Gradientech founded?

    Gradientech was founded in 2009.

  • Where is Gradientech headquartered?

    Gradientech is headquartered in Uppsala, Sweden.

  • What is the size of Gradientech?

    Gradientech has 36 total employees.

  • What industry is Gradientech in?

    Gradientech’s primary industry is Diagnostic Equipment.

  • Is Gradientech a private or public company?

    Gradientech is a Private company.

  • What is the current valuation of Gradientech?

    The current valuation of Gradientech is .

  • What is Gradientech’s current revenue?

    The current revenue for Gradientech is .

  • How much funding has Gradientech raised over time?

    Gradientech has raised $30.7M.

  • Who are Gradientech’s investors?

    Hardy Diagnostics, Polynom Investment, Axilium Holding, , and European Structural And Investment Funds are 5 of 13 investors who have invested in Gradientech.

  • Who are Gradientech’s competitors?

    Illumina is a competitor of Gradientech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process